Locations
Tirat Carmel, Israel
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2009
MeMed is a transformative diagnostics company that leverages machine learning to decode the immune system's signals, providing actionable insights for clinicians. Their flagship products, Me Med BV and Me Med Key, enable rapid differentiation between bacterial and viral infections, addressing critical challenges in infectious disease management. With FDA clearance and validation in over 20,000 patients, MeMed is positioned to improve patient care and reduce antibiotic misuse, a significant issue in healthcare. The company's innovative approach combines molecular immunology and advanced algorithms, setting it apart in the diagnostics market.
Something looks off?